LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.
Saved in:
| Title: | LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions. |
|---|---|
| Authors: | Yu K; Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Davidson CL; Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Wójtowicz A; Infectious Diseases Service, University Hospital and University of Lausanne, Lausanne, Switzerland., Lisboa L; Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Wang T; Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Airo AM; Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Villard J; Immunology and Transplant Unit, Service of Nephrology, Geneva University Hospital, Geneva, Switzerland., Buratto J; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Department of Infectious Diseases, Karolinska University Hospital, Solna, Stockholm, Sweden., Sandalova T; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Department of Infectious Diseases, Karolinska University Hospital, Solna, Stockholm, Sweden., Achour A; Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Department of Infectious Diseases, Karolinska University Hospital, Solna, Stockholm, Sweden., Humar A; Multi-Organ Transplant Program, University of Toronto, Toronto, Ontario, Canada., Boggian K; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Cusini A; Department of Infectious Diseases and Hospital Epidemiology, Bern University Hospital and University of Bern, Bern, Switzerland., van Delden C; Transplant Infectious Diseases Unit, University Hospitals Geneva, Geneva, Switzerland., Egli A; Division of Clinical Microbiology, University Hospital Basel, Basel, Switzerland.; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland., Manuel O; Infectious Diseases Service and Transplantation Center, University Hospital and University of Lausanne, Lausanne, Switzerland., Mueller N; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Bochud PY; Infectious Diseases Service, University Hospital and University of Lausanne, Lausanne, Switzerland., Burshtyn DN; Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada. |
| Corporate Authors: | Swiss Transplant Cohort Study |
| Source: | The Journal of clinical investigation [J Clin Invest] 2018 Apr 02; Vol. 128 (4), pp. 1523-1537. Date of Electronic Publication: 2018 Mar 12. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
